# Trade Mark Journal No.2026/013 27 March 2026

## UK00004348236 3 March 2026 (5)

R1 THERAPEUTICS

International priority date claimed: 29 October 2025 (United States of America) (99469478)

Class 5
  Pharmaceuticals; medical preparations and substances; Pharmaceutical preparations for the treatment of neurological, immunological, nephrological, oncological, infectious, cardiovascular, vascular, central and peripheral nervous system, autoimmune, endocrinological, gastrointestinal, genetic, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, ocular, neuromuscular, and viral diseases, conditions and disorders.

R1 Therapeutics, Inc.

Representative: CMS Cameron McKenna Nabarro Olswang LLP